(1S,2R,5R)-2-(chlorocarbonyl)-5-methylcyclohexyl acetate | 478028-39-6

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 卤代烷
• 英文名称: (1S,2R,5R)-2-(chlorocarbonyl)-5-methylcyclohexyl acetate
• 英文别名: acetic acid 2-chlorocarbonyl-5-methyl-cyclohexyl ester；[(1S,2R,5R)-2-carbonochloridoyl-5-methylcyclohexyl] acetate
• CAS: 478028-39-6
• 化学式: C₁₀H₁₅ClO₃
• 分子量: 218.68
• InChiKey: FABPASRXDSSEPV-VDAHYXPESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (1S,2R,5R)-2-(chlorocarbonyl)-5-methylcyclohexyl acetate 在 lithium hydroxide 作用下， 以 四氢呋喃 、 水 、 1,2-二氯乙烷 为溶剂， 生成 5-(3,3-dimethylbut-1-ynyl)-3-((1R,2S,4R)-2-hydroxy-4-methyl-N-((1r,4R)-4-(tetrahydrofuran-3-yloxy)cyclohexyl)cyclohexanecarboxamido)thiophene-2-carboxylic acid
  参考文献：
  名称：

  Discovery of GS-9669, a Thumb Site II Non-Nucleoside Inhibitor of NS5B for the Treatment of Genotype 1 Chronic Hepatitis C Infection

  摘要：

  Investigation of thiophene-2-carboxylic acid HCV NS5B site II inhibitors, guided by measurement of cell culture medium binding, revealed the structure activity relationships for intrinsic cellular potency. The pharmacokinetic profile was enhanced through incorporation of heterocyclic ethers on the N-alkyl substituent. Hydroxyl groups were incorporated to modulate protein binding. Intrinsic potency was further improved through enantiospecific introduction of an olefin in the N-acyl motif, resulting in the discovery of the phase 2 clinical candidate GS-9669. The unexpected activity of this compound against the clinically relevant NS5B M423T mutant, relative to the wild type, was shown to arise from both the N-alkyl substituent and the N-acyl group.

  DOI：

  10.1021/jm401420j
• 作为产物：
  描述：

  (1r,2s,4r)-2-(acetyloxy)-4-methylcyclohexanecarboxylic acid 在 N,N-二甲基甲酰胺 草酰氯 作用下， 以 二氯甲烷 为溶剂， 反应 4.0h， 以99%的产率得到(1S,2R,5R)-2-(chlorocarbonyl)-5-methylcyclohexyl acetate
  参考文献：
  名称：

  [EN] COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
  [FR] COMPOSES ET PROCEDES DE TRAITEMENT OU DE PREVENTION D'INFECTIONS A FLAVIVIRUS

  摘要：

  本发明提供了一种表示为式(I)的新化合物，或其在药学上可接受的盐，用于治疗黄病毒科病毒感染。

  公开号：

  WO2004052885A1

文献信息

• INHIBITORS OF FLAVIVIRIDAE VIRUSES
  申请人：Canales Eda

  公开号：US20110020278A1

  公开（公告）日：2011-01-27

  Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.

  提供的是I式化合物： 及其药用可接受的盐和酯。所提供的化合物、组合物和方法对于治疗黄病毒科病毒感染，特别是丙型肝炎感染，是有用的。
• Substituted thiophenes
  申请人：Thede Kai

  公开号：US20070099929A1

  公开（公告）日：2007-05-03

  The invention relates to substituted thiophenes and processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particular for hepatitis C viruses.

  这项发明涉及替代噻吩及其制备方法，其用于治疗和/或预防疾病，以及用于生产治疗和/或预防疾病的药物，特别是用作抗病毒剂，尤其是对丙型肝炎病毒的使用。
• Compounds and methods for the treatment or prevention of Flavivirus infections
  申请人：Chan Chun Kong Laval

  公开号：US20060142347A1

  公开（公告）日：2006-06-29

  The present invention provides novel compounds represented by formula I: or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.

  本发明提供了由公式I表示的新化合物：或其药学上可接受的盐，用于治疗黄病毒科病毒感染。
• COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
  申请人：Shire BioChem Inc.

  公开号：US20040116509A1

  公开（公告）日：2004-06-17

  The present invention provides novel compounds represented by formula I: 1 or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.

  本发明提供了由公式I表示的新化合物：1或其药学上可接受的盐，用于治疗黄病毒科病毒感染。
• Compounds and methods for the treatment or prevention of flavivirus infections
  申请人：Chan Chun Kong Laval

  公开号：US08357718B2

  公开（公告）日：2013-01-22

  Compounds represented by formula: wherein X, Y and Z are as defined herein, pharmaceutically acceptable salts thereof, and related compounds, are suitable for use in treating or preventing a Flaviviridae viral infection in a host.

  化学式为：其中X，Y和Z的定义如下，其药学上可接受的盐以及相关化合物，适用于用于治疗或预防宿主中的黄病毒科病毒感染。